北京大学第三医院教授、北京大学前沿交叉研究院副院长、国家妇产疾病临床医学研究中心副主任；国家杰青 / 国家优青 / 国家海外优青基金获得者。研究领域为以蛋白质组学为框架的肿瘤发生与治疗新策略。曾荣获美国Susan G Komen奖项、美国卵巢癌慈善基金OCRF奖项、国家卫健委科技进步一等奖等。承担国家自然科学基金委“基础科学中心”、“创新群体”、科技部国家重点研发专项等。发表SCI论文50余篇，总引用次数2700余次，代表作包括Nature、Cancer Cell、Cell Research、Nature Chemical Biology、Genes & Development、Cell Rep Medicine、Science Advances、Nature Communications、PNAS等。

1. 全国交叉学科研究院院长联席会 办公室主任；

2. National Science Review (IF 20.0)，编委

1. 基金委基础科学中心（五主要成员之一），6000万，在研；

2. 基金委杰出青年科学基金，400万，在研；等

1. Yin D, Wang P, Hao Y, Yue W, Jiang X, Yao K, Wang Y, Hang X, Xiao A, Zhou J, Lin L, Rao Z, Wu H, Liu F, Dong Z, Wu M, Xu C, Huang J, Chang H, Fan Y, Yu X, Yu C, Chang L, Li M. A battery-free nanofluidic intracellular delivery patch for internal organs. Nature 2025.

2. Wu Y, Wang C, Guo Y, Zhang Y, Zhang X, Wang P, Yue W, Zhu X, Liu Z, Zhang Y, Guo H, Han L, Li M. Small extracellular vesicle-based one-step high-throughput microfluidic platform for epithelial ovarian cancer diagnosis. J. Nanobiotechnology 2025

3. Zhang S, Xie B, Zhu X, Dong S, Li M. Lactylation in cancer: Unveiling new layers of complexity. Innovation 2025

4. Shi Y, Zheng H, Wang T, Zhou S, Zhao S, Li M*, Cao B*. Targeting KRAS: from metabolic regulation to cancer treatment. Mol. Cancer 2025

5. Yue W, Li X, Zhan X, Wang L, Ma J, Bi M, Wang Q, Gu X, Xie B, Liu T, Guo H, Zhu X, Song C, Qiao J, Li M. PARP inhibitors suppress tumours via centrosome error-induced senescence independent of DNA damage response. EBioMedicine 2024.

6. Xie B, Zhang M, Li J, Cui J, Zhang P, Liu F, Wu Y, Deng W, Ma J, Li X, Pan B, Zhang B, Zhang H, Luo A, Xu Y*, Li M*, Pu Y*. KAT8-catalyzed lactylation promotes eEF1A2-mediated protein synthesis and colorectal carcinogenesis. PNAS 2023

7. Wang P, Ma J, Li W, Wang Q, Xiao Y, Jiang Y, Gu X, Wu Y, Dong S, Guo H, Li M. Profiling the metabolome of uterine fluid for early detection of ovarian cancer. Cell Rep Med 2023

8. Xie B, Pu Y, Chen W, Yue W, Ma J, Jiang Y, Wu J, Lin Y, Liang X, Wang C, Zou P, Li M. Proteomic Mapping and Targeting of Mitotic Pericentriolar Material in Tumors Bearing Centrosome Amplification. Cancer Research 2022

9. Xiao Y, Bi M, Guo H, Li M. Multi-omics approaches for biomarker discovery in early ovarian cancer diagnosis. EBioMedicine 2022

10. Li W, Gu X, Liu C, Shi Y, Wang P, Zhang N, Wu R, Leng L, Xie B, Song C, Li M. A synergetic effect of BARD1 mutations on tumorigenesis. Nature Commun 2021 等。